Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


GREY:BIOAF - Post by User

Comment by Boomskidon May 19, 2023 3:46pm
104 Views
Post# 35457063

RE:RE:RE:Knock at The Door

RE:RE:RE:Knock at The Door
Hahahaha! You're running out of material, TheTruth1234. 
 
I take full responsibility for my choices. I also take responsibility for the huge mistake of choosing Bioasis over another client in 2020 during Covid. I couldn't handle both clients for various reasons. I have always felt a responsibility to Bioasis shareholders and many of them became friends. I felt I owed them my allegiance, especially with that stupid Chiesi deal. Rathjen worried me, incompetent, certainly secretive and controlling, all the worst traits for a CEO.
 
It's also true that although I had little confidence in Rathjen, I nevertheless had no idea that such a promising technology, xB3, not only functionally promising but of huge potential commercial value, could be mismanaged so badly since 2008. I walked a fine line for years, trying to be supportive but still being free to criticize. Rathjen never realized that credibility comes from recognizing both the good and the bad and publicly dealing with them. 
 
So staying with Bioasis cost me, not as much as investing in Bioasis cost many of you, but still, it's cost me a lot. I certainly do blame Rathjen for the same things that shareholders ought to blame her for. 
 
TheTruth1234 will continue to attack and and try to ridicule me, but he’s getting repetitive now. Going forward, I may or may not respond to him. 
 
He will ridicule me for my age and because of bankruptcy at my age. I would very much like to be wealthy and 53 years old, as he is. But his ridicule says more about his character than about mine. I can financially recover. He will always be what he is.
 
jd
<< Previous
Bullboard Posts
Next >>